Andrew T. Watt

4.6k citations

26 papers · 2.9k indexed · 1 hit paper · h-index 18

Molecular Biology top 5%
Cancer Research top 1%
Cellular and Molecular Neuroscience top 10%
Physiology
Epidemiology

Co-authors: Susan M. Freier C. Frank Bennett Alok Sharma Kannanganattu V. Prasanth Zhen Shen Jonathan D. Ellis Qun Pan Vidisha Tripathi
Topics: RNA Research and Splicing (7 papers)RNA and protein synthesis mechanisms (6 papers)Advanced biosensing and bioanalysis techniques (4 papers)
Cited by: Cancer Research Molecular Biology Physiology
Journals: Journal of the American Chemical Society Nucleic Acids Research Journal of Clinical Investigation
Partner nations: United States Canada United Kingdom

In The Last Decade

Andrew T. Watt

24 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation

2010 1.7k citations Vidisha Tripathi, Jonathan D. Ellis et al. Molecular Cell profile →

Peers

Countries citing papers authored by Andrew T. Watt

Since Specialization

Citations

This map shows the geographic impact of Andrew T. Watt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew T. Watt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew T. Watt more than expected).

Fields of papers citing papers by Andrew T. Watt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew T. Watt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew T. Watt. The network helps show where Andrew T. Watt may publish in the future.

Co-authorship network of co-authors of Andrew T. Watt

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew T. Watt. A scholar is included among the top collaborators of Andrew T. Watt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew T. Watt. Andrew T. Watt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice 2022 ·Molecular Therapy ·Ya‐Wen Yang,Bibek Poudel,(unknown),Poonam Dhillon,Rojesh Shrestha,Ziyuan Ma,Junnan Wu,(unknown),Jeffrey B. Kopp,Sheri Booten,Danielle Gattis,Andrew T. Watt,Matthew Palmer,Mariam Aghajan,Katalin Suszták	11
2	Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy 2020 ·Nucleic Acid Therapeutics ·Andrew T. Watt,(unknown),Eric E. Swayze,Susan M. Freier	21
3	Antisense oligonucleotide treatment ameliorates IFN-γ–induced proteinuria in APOL1-transgenic mice 2019 ·JCI Insight ·Mariam Aghajan,Sheri Booten,Magnus Althage,Christopher E. Hart,Anette Ericsson,(unknown),Joseph Ochaba,(unknown),Judith Hartleib,Steven Kuntz,Danielle Gattis,Christine Ahlström,Andrew T. Watt,Jeffery A. Engelhardt,Brett P. Monia,Maria Chiara Magnone,Shuling Guo	69
4	Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice 2015 ·Immunobiology ·Tamar R. Grossman,Lisa Hettrick,Robert B. Johnson,Gene Hung,Raechel Peralta,Andrew T. Watt,Scott P. Henry,Peter Adamson,Brett P. Monia,Michael L. McCaleb	27
5	Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients 2014 ·PLoS ONE ·Niels H. Skotte,Amber L. Southwell,Michael E. Østergaard,Jeffrey B. Carroll,Simon C. Warby,Crystal N. Doty,Eugenia Petoukhov,Kuljeet Vaid,Holly Kordasiewicz,Andrew T. Watt,Susan M. Freier,Gene Hung,Punit P. Seth,C. Frank Bennett,Eric E. Swayze,Michael R. Hayden	85
6	In Vivo Evaluation of Candidate Allele-specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides 2014 ·Molecular Therapy ·Amber L. Southwell,Niels H. Skotte,Holly Kordasiewicz,Michael E. Østergaard,Andrew T. Watt,Jeffrey B. Carroll,Crystal N. Doty,Erika B. Villanueva,Eugenia Petoukhov,Kuljeet Vaid,Yuanyun Xie,Susan M. Freier,Eric E. Swayze,Punit P. Seth,(unknown),Michael R. Hayden	107
7	Targeting of Repeated Sequences Unique to a Gene Results in Significant Increases in Antisense Oligonucleotide Potency 2014 ·PLoS ONE ·Timothy A. Vickers,Susan M. Freier,Huynh‐Hoa Bui,Andrew T. Watt,Stanley T. Crooke	14
8	Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin–related liver disease in mice 2013 ·Journal of Clinical Investigation ·Shuling Guo,Sheri Booten,Mariam Aghajan,Gene Hung,Chenguang Zhao,Keith Blomenkamp,Danielle Gattis,Andrew T. Watt,Susan M. Freier,Jeffrey Teckman,Michael L. McCaleb,Brett P. Monia	55
9	Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS 2013 ·Nucleic Acids Research ·Michael E. Østergaard,Amber L. Southwell,Holly Kordasiewicz,Andrew T. Watt,Niels H. Skotte,Crystal N. Doty,Kuljeet Vaid,Erika B. Villanueva,Eric E. Swayze,C. Frank Bennett,Michael R. Hayden,Punit P. Seth	122
10	Control of RNA processing by a large non-coding RNA over-expressed in carcinomas 2011 ·FEBS Letters ·Rui Lin,(unknown),Chris Black,Andrew T. Watt,Eric G. Marcusson,Susan M. Freier,Thomas S. Edgington	69
11	Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis 2011 ·Amyloid ·Barbara Kluve‐Beckerman,Joyce Hardwick,(unknown),Merrill D. Benson,Brett P. Monia,Andrew T. Watt,Rosanne M. Crooke,Adam E. Mullick	20
12	The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylationbreakdown → 2010 ·Molecular Cell ·Vidisha Tripathi,Jonathan D. Ellis,Zhen Shen,David Song,Qun Pan,Andrew T. Watt,Susan M. Freier,C. Frank Bennett,Alok Sharma,Paula A. Bubulya,Benjamin J. Blencowe,Supriya G. Prasanth,Kannanganattu V. Prasanth	1749
13	An Exocyclic Methylene Group Acts As a Bioisostere of the 2′-Oxygen Atom in LNA 2010 ·Journal of the American Chemical Society ·Punit P. Seth,Charles Allerson,Andrés Berdeja,Andrew Siwkowski,Pradeep S. Pallan,Hans Gaus,Thazha P. Prakash,Andrew T. Watt,Martin Egli,Eric E. Swayze	69
14	In vitro and in vivo effects of an α3 neuronal nicotinic acetylcholine receptor antisense oligonucleotide 2004 ·Molecular Brain Research ·Monique R. Adams,Arthur L. Nikkel,Diana L. Donnelly‐Roberts,Andrew T. Watt,Joseph F. Johnston,Lex M. Cowsert,(unknown),Paul E. Kroeger,Leigh Frost,Peter Curzon,Michael Decker,Robert S. Bitner	8
15	Antisense Oligonucleotide Inhibition of Bcl-xL and Bid Expression in Liver Regulates Responses in a Mouse Model of Fas-Induced Fulminant Hepatitis 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Hong Zhang,Jennifer K. Taylor,(unknown),(unknown),Susan Murray,Jacqueline R. Wyatt,Andrew T. Watt,Seongjoon Koo,(unknown),(unknown),Nicholas M. Dean	17
16	Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats 2002 ·Pain ·Prisca Honoré,Karen Kage,Joseph P. Mikusa,Andrew T. Watt,Joseph F. Johnston,Jacqueline R. Wyatt,Connie R. Faltynek,Michael F. Jarvis,Kevin J. Lynch	190
17	Peptide Nucleic Acids Are Potent Modulators of Endogenous Pre-mRNA Splicing of the Murine Interleukin-5 Receptor-α Chain 2001 ·Biochemistry ·James G. Karras,Martin A. Maier,Tao Lü,Andrew T. Watt,Muthiah Manoharan	52
18	Variations in mRNA Content Have No Effect on the Potency of Antisense Oligonucleotides 2000 ·Antisense and Nucleic Acid Drug Development ·Loren Miraglia,Andrew T. Watt,Mark Graham,Stanley T. Crooke	12
19	The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent 1999 ·Journal of Virology ·Nicholas J. DePolo,(unknown),Mordechai Bodner,Andrew T. Watt,(unknown),Judith S. Greengard,Krishna K. Murthy,Thomas W. Dubensky,Douglas J. Jolly	40
20	A Comparison of the Effects of Mibefradil and Atenolol on Regression of Left Ventricular Hypertrophy in Hypertensive Patients 1998 ·Cardiology ·Christer Höglund,Renata Cífková,A Mimran,(unknown),Andrew T. Watt,(unknown),(unknown)	14

About Andrew T. Watt

Andrew T. Watt is a scholar working on Nephrology, Molecular Biology and Cancer Research, having authored 26 papers that have together received 2.9k indexed citations. Recurring topics across this work include RNA Research and Splicing (7 papers), RNA and protein synthesis mechanisms (6 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Cancer Research (1.6k citations), Molecular Biology (2.4k citations) and Physiology (132 citations). Andrew T. Watt has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Susan M. Freier, C. Frank Bennett, Alok Sharma, Kannanganattu V. Prasanth, Zhen Shen, Jonathan D. Ellis, Qun Pan, Vidisha Tripathi, Supriya G. Prasanth and Benjamin J. Blencowe. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact